Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 0.00% | 88.46 | 1.3% | $921.65m | |
| AMGN | Amgen Inc. | 0.03% | 191.29 | 1.2% | $567.39m | |
| ONCE | Spark Therapeutics, Inc. | 0.18% | 113.79 | 11.2% | $468.71m | |
| GILD | Gilead Sciences, Inc. | -0.70% | 65.17 | 0.9% | $447.70m | |
| BIIB | Biogen Inc. | -1.28% | 325.64 | 1.3% | $355.85m | |
| BPTH | Bio-Path Holdings, Inc. | -5.38% | 27.82 | 190.1% | $311.93m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.28% | 409.18 | 2.6% | $285.34m | |
| ILMN | Illumina, Inc. | -1.44% | 305.39 | 3.5% | $272.21m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.20% | 187.71 | 1.9% | $243.74m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.06% | 128.44 | 15.4% | $216.62m | |
| EXAS | Exact Sciences Corporation | -3.87% | 91.52 | 25.3% | $192.07m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.96% | 134.78 | 2.0% | $180.79m | |
| A | Agilent Technologies, Inc. | -0.58% | 80.63 | 1.6% | $154.79m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.58% | 93.99 | 4.3% | $100.08m | |
| IONS | Ionis Pharmaceuticals, Inc. | 0.10% | 78.62 | 8.3% | $100.04m |
Company Profile
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel medicines to address serious medical conditions. Its pipeline includes hemostasis such as Factor VIIa marzeptacog alfa, Factor IX dalcinonacog alfa, and Factor Xa; and anti-complement. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.